4.84 USD
+0.15 (+3.2%)
At close: Nov 19, 2024
4.85 USD
+0.01 (+0.21%)
After Hours: 11/19/2024, 8:18:05 PM
Overall EXAI gets a fundamental rating of 2 out of 10. We evaluated EXAI against 524 industry peers in the Biotechnology industry. EXAI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EXAI is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year EXAI has reported negative net income.
- In the past year EXAI has reported a negative cash flow from operations.
- EXAI had negative earnings in each of the past 5 years.
- In the past 5 years EXAI reported 4 times negative operating cash flow.
1.2 Ratios
- EXAI's Return On Assets of -25.37% is fine compared to the rest of the industry. EXAI outperforms 73.06% of its industry peers.
- With a decent Return On Equity value of -36.43%, EXAI is doing good in the industry, outperforming 75.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.37% | ||
| ROE | -36.43% | ||
| ROIC | N/A |
ROA(3y)-18.33%
ROA(5y)-19.31%
ROE(3y)-25.04%
ROE(5y)-27.69%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- EXAI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- EXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for EXAI has been increased compared to 1 year ago.
- Compared to 1 year ago, EXAI has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.78, we must say that EXAI is in the distress zone and has some risk of bankruptcy.
- EXAI has a Altman-Z score of 1.78. This is in the better half of the industry: EXAI outperforms 69.19% of its industry peers.
- EXAI has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
- EXAI's Debt to Equity ratio of 0.05 is on the low side compared to the rest of the industry. EXAI is outperformed by 60.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.78 |
ROIC/WACCN/A
WACC8.54%
2.3 Liquidity
- EXAI has a Current Ratio of 6.22. This indicates that EXAI is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 6.22, EXAI is in the better half of the industry, outperforming 62.68% of the companies in the same industry.
- EXAI has a Quick Ratio of 6.22. This indicates that EXAI is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 6.22, EXAI is in the better half of the industry, outperforming 63.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.22 | ||
| Quick Ratio | 6.22 |
3. Growth
3.1 Past
- EXAI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.11%.
- The Revenue for EXAI has decreased by -19.64% in the past year. This is quite bad
- EXAI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.43% yearly.
EPS 1Y (TTM)5.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-24.14%
Revenue 1Y (TTM)-19.64%
Revenue growth 3Y17.43%
Revenue growth 5YN/A
Sales Q2Q%46.6%
3.2 Future
- Based on estimates for the next years, EXAI will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.83% on average per year.
- EXAI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.58% yearly.
EPS Next Y42.38%
EPS Next 2Y17.98%
EPS Next 3Y19.83%
EPS Next 5YN/A
Revenue Next Year63.9%
Revenue Next 2Y8.4%
Revenue Next 3Y13.58%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- EXAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EXAI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as EXAI's earnings are expected to grow with 19.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.98%
EPS Next 3Y19.83%
5. Dividend
5.1 Amount
- No dividends for EXAI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EXSCIENTIA PLC / EXAI FAQ
What is the fundamental rating for EXAI stock?
ChartMill assigns a fundamental rating of 2 / 10 to EXAI.
What is the valuation status of EXSCIENTIA PLC (EXAI) stock?
ChartMill assigns a valuation rating of 0 / 10 to EXSCIENTIA PLC (EXAI). This can be considered as Overvalued.
Can you provide the profitability details for EXSCIENTIA PLC?
EXSCIENTIA PLC (EXAI) has a profitability rating of 1 / 10.